Annual CFI
-$14.08 B
-$9.12 B-183.93%
31 December 2023
Summary:
Merck & Co annual cash flow from investing activities is currently -$14.08 billion, with the most recent change of -$9.12 billion (-183.93%) on 31 December 2023. During the last 3 years, it has fallen by -$4.64 billion (-49.14%). MRK annual CFI is now -426.45% below its all-time high of $4.31 billion, reached on 31 December 2018.MRK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$3.85 B
-$2.78 B-259.68%
30 September 2024
Summary:
Merck & Co quarterly cash flow from investing activities is currently -$3.85 billion, with the most recent change of -$2.78 billion (-259.68%) on 30 September 2024. Over the past year, it has dropped by -$3.51 billion (-1051.20%). MRK quarterly CFI is now -132.01% below its all-time high of $12.01 billion, reached on 30 September 2009.MRK Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$6.24 B
-$3.51 B-128.80%
30 September 2024
Summary:
Merck & Co TTM cash flow from investing activities is currently -$6.24 billion, with the most recent change of -$3.51 billion (-128.80%) on 30 September 2024. Over the past year, it has increased by +$9.65 billion (+60.73%). MRK TTM CFI is now -140.06% below its all-time high of $15.57 billion, reached on 30 September 2009.MRK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRK Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -183.9% | -1051.2% | +60.7% |
| 3 y3 years | -49.1% | -262.4% | +32.8% |
| 5 y5 years | -426.4% | -2113.1% | -2099.0% |
MRK Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -183.9% | +14.9% | -7354.7% | +68.1% | -128.8% | +63.3% |
| 5 y | 5 years | -426.4% | +14.9% | -2113.1% | +68.1% | -2099.0% | +63.3% |
| alltime | all time | -426.4% | +14.9% | -132.0% | +70.1% | -140.1% | +63.3% |
Merck & Co Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.85 B(+259.7%) | -$6.24 B(+128.8%) |
| June 2024 | - | -$1.07 B(-22.3%) | -$2.73 B(-79.2%) |
| Mar 2024 | - | -$1.38 B(-2696.2%) | -$13.10 B(-7.0%) |
| Dec 2023 | -$14.08 B(+183.9%) | $53.00 M(-115.9%) | -$14.08 B(-11.3%) |
| Sept 2023 | - | -$334.00 M(-97.1%) | -$15.88 B(-3.8%) |
| June 2023 | - | -$11.44 B(+385.1%) | -$16.51 B(+168.7%) |
| Mar 2023 | - | -$2.36 B(+35.0%) | -$6.15 B(+23.9%) |
| Dec 2022 | -$4.96 B(-70.0%) | -$1.75 B(+81.7%) | -$4.96 B(-67.5%) |
| Sept 2022 | - | -$962.00 M(-10.7%) | -$15.26 B(-0.6%) |
| June 2022 | - | -$1.08 B(-8.2%) | -$15.36 B(-9.6%) |
| Mar 2022 | - | -$1.17 B(-90.3%) | -$16.99 B(+2.6%) |
| Dec 2021 | -$16.55 B(+75.3%) | -$12.05 B(+1035.6%) | -$16.55 B(+78.3%) |
| Sept 2021 | - | -$1.06 B(-60.8%) | -$9.28 B(-10.5%) |
| June 2021 | - | -$2.71 B(+266.8%) | -$10.38 B(+21.3%) |
| Mar 2021 | - | -$738.00 M(-84.6%) | -$8.55 B(-9.4%) |
| Dec 2020 | -$9.44 B(+259.2%) | -$4.78 B(+121.7%) | -$9.44 B(+74.0%) |
| Sept 2020 | - | -$2.15 B(+144.3%) | -$5.43 B(+76.1%) |
| June 2020 | - | -$882.00 M(-45.8%) | -$3.08 B(-33.4%) |
| Mar 2020 | - | -$1.63 B(+113.4%) | -$4.63 B(+75.9%) |
| Dec 2019 | -$2.63 B(-160.9%) | -$763.00 M(-499.5%) | -$2.63 B(-942.6%) |
| Sept 2019 | - | $191.00 M(-107.9%) | $312.00 M(-82.5%) |
| June 2019 | - | -$2.42 B(-759.0%) | $1.78 B(-63.5%) |
| Mar 2019 | - | $368.00 M(-83.1%) | $4.88 B(+13.1%) |
| Dec 2018 | $4.31 B(+61.0%) | $2.18 B(+31.2%) | $4.31 B(+107.6%) |
| Sept 2018 | - | $1.66 B(+146.7%) | $2.08 B(+90.8%) |
| June 2018 | - | $673.00 M(-441.6%) | $1.09 B(-253.2%) |
| Mar 2018 | - | -$197.00 M(+239.7%) | -$711.00 M(-126.5%) |
| Dec 2017 | $2.68 B(-183.5%) | -$58.00 M(-108.6%) | $2.68 B(+1439.7%) |
| Sept 2017 | - | $671.00 M(-159.5%) | $174.00 M(-112.5%) |
| June 2017 | - | -$1.13 B(-135.3%) | -$1.39 B(-21.1%) |
| Mar 2017 | - | $3.19 B(-224.6%) | -$1.76 B(-45.2%) |
| Dec 2016 | -$3.21 B(-32.5%) | -$2.56 B(+188.0%) | -$3.21 B(+154.0%) |
| Sept 2016 | - | -$890.00 M(-40.6%) | -$1.26 B(+190.6%) |
| June 2016 | - | -$1.50 B(-186.0%) | -$435.00 M(-112.1%) |
| Mar 2016 | - | $1.74 B(-382.2%) | $3.59 B(-175.4%) |
| Dec 2015 | -$4.76 B(+1172.2%) | -$617.00 M(+911.5%) | -$4.76 B(-255.3%) |
| Sept 2015 | - | -$61.00 M(-102.4%) | $3.06 B(-612.2%) |
| June 2015 | - | $2.52 B(-138.2%) | -$598.00 M(-81.1%) |
| Mar 2015 | - | -$6.61 B(-191.7%) | -$3.17 B(+748.1%) |
| Dec 2014 | -$374.00 M(-88.1%) | $7.20 B(-293.6%) | -$374.00 M(-94.2%) |
| Sept 2014 | - | -$3.72 B(+7495.9%) | -$6.40 B(+35.7%) |
| June 2014 | - | -$49.00 M(-98.7%) | -$4.72 B(-18.7%) |
| Mar 2014 | - | -$3.81 B(-423.4%) | -$5.80 B(+84.3%) |
| Dec 2013 | -$3.15 B(-53.7%) | $1.18 B(-157.8%) | -$3.15 B(-63.9%) |
| Sept 2013 | - | -$2.04 B(+79.5%) | -$8.72 B(+2.3%) |
| June 2013 | - | -$1.14 B(-1.6%) | -$8.53 B(+10.9%) |
| Mar 2013 | - | -$1.15 B(-73.8%) | -$7.69 B(+13.0%) |
| Dec 2012 | -$6.80 B(+135.5%) | -$4.40 B(+139.2%) | -$6.80 B(+66.3%) |
| Sept 2012 | - | -$1.84 B(+517.1%) | -$4.09 B(+62.7%) |
| June 2012 | - | -$298.00 M(+10.4%) | -$2.52 B(-23.0%) |
| Mar 2012 | - | -$270.00 M(-84.0%) | -$3.27 B(+13.0%) |
| Dec 2011 | -$2.89 B(-17.4%) | -$1.68 B(+540.3%) | -$2.89 B(+30.6%) |
| Sept 2011 | - | -$263.00 M(-74.9%) | -$2.21 B(+26.0%) |
| June 2011 | - | -$1.05 B(-1098.1%) | -$1.76 B(+619.7%) |
| Mar 2011 | - | $105.00 M(-110.4%) | -$244.00 M(-93.0%) |
| Dec 2010 | -$3.50 B(-210.8%) | -$1.01 B(-619.1%) | -$3.50 B(-77.2%) |
| Sept 2010 | - | $194.00 M(-58.2%) | -$15.35 B(+334.1%) |
| June 2010 | - | $464.00 M(-114.7%) | -$3.54 B(+155.9%) |
| Mar 2010 | - | -$3.15 B(-75.5%) | -$1.38 B(-143.8%) |
| Dec 2009 | $3.16 B(-272.1%) | -$12.86 B(-207.1%) | $3.16 B(-79.7%) |
| Sept 2009 | - | $12.01 B(+358.7%) | $15.57 B(+5439.2%) |
| June 2009 | - | $2.62 B(+88.4%) | $281.10 M(-112.0%) |
| Mar 2009 | - | $1.39 B(-409.0%) | -$2.35 B(+28.0%) |
| Dec 2008 | -$1.83 B(-34.7%) | -$449.80 M(-86.3%) | -$1.83 B(-17.8%) |
| Sept 2008 | - | -$3.28 B(>+9900.0%) | -$2.23 B(-328.7%) |
| June 2008 | - | -$9.00 M(-100.5%) | $975.80 M(+160.8%) |
| Mar 2008 | - | $1.90 B(-324.4%) | $374.20 M(-113.3%) |
| Dec 2007 | -$2.81 B | -$847.80 M(+1107.7%) | -$2.81 B(-23.2%) |
| Sept 2007 | - | -$70.20 M(-88.5%) | -$3.66 B(-34.2%) |
| June 2007 | - | -$610.60 M(-52.3%) | -$5.55 B(-27.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$1.28 B(-24.4%) | -$7.67 B(+57.1%) |
| Dec 2006 | -$4.88 B(-315.4%) | -$1.69 B(-13.9%) | -$4.88 B(-412.3%) |
| Sept 2006 | - | -$1.97 B(-27.8%) | $1.56 B(-52.3%) |
| June 2006 | - | -$2.73 B(-281.1%) | $3.28 B(-34.2%) |
| Mar 2006 | - | $1.50 B(-68.3%) | $4.98 B(+119.7%) |
| Dec 2005 | $2.27 B(-238.4%) | $4.75 B(-1951.7%) | $2.27 B(-196.7%) |
| Sept 2005 | - | -$256.70 M(-74.8%) | -$2.34 B(+4.0%) |
| June 2005 | - | -$1.02 B(-15.6%) | -$2.25 B(-9.1%) |
| Mar 2005 | - | -$1.21 B(-951.9%) | -$2.48 B(+51.4%) |
| Dec 2004 | -$1.64 B(-61.3%) | $141.90 M(-184.7%) | -$1.64 B(+26.5%) |
| Sept 2004 | - | -$167.60 M(-86.5%) | -$1.30 B(-44.6%) |
| June 2004 | - | -$1.25 B(+239.2%) | -$2.34 B(-6.3%) |
| Mar 2004 | - | -$367.10 M(-175.8%) | -$2.50 B(-41.0%) |
| Dec 2003 | -$4.23 B(+12.3%) | $484.60 M(-140.0%) | -$4.23 B(-7.4%) |
| Sept 2003 | - | -$1.21 B(-13.6%) | -$4.57 B(-2.1%) |
| June 2003 | - | -$1.40 B(-33.3%) | -$4.67 B(-3.0%) |
| Mar 2003 | - | -$2.10 B(-1559.9%) | -$4.81 B(+27.7%) |
| Dec 2002 | -$3.77 B(-3.3%) | $144.00 M(-111.0%) | -$3.77 B(-8.8%) |
| Sept 2002 | - | -$1.31 B(-15.4%) | -$4.13 B(+3.9%) |
| June 2002 | - | -$1.55 B(+46.2%) | -$3.98 B(+4.7%) |
| Mar 2002 | - | -$1.06 B(+381.0%) | -$3.80 B(-2.6%) |
| Dec 2001 | -$3.90 B(+7.0%) | -$219.80 M(-80.9%) | -$3.90 B(-14.1%) |
| Sept 2001 | - | -$1.15 B(-15.6%) | -$4.53 B(-0.4%) |
| June 2001 | - | -$1.37 B(+18.0%) | -$4.55 B(+3.3%) |
| Mar 2001 | - | -$1.16 B(+35.1%) | -$4.41 B(+21.0%) |
| Dec 2000 | -$3.64 B(+29.3%) | -$856.90 M(-26.8%) | -$3.64 B(-2.2%) |
| Sept 2000 | - | -$1.17 B(-4.1%) | -$3.72 B(+2.0%) |
| June 2000 | - | -$1.22 B(+211.6%) | -$3.65 B(+166.9%) |
| Mar 2000 | - | -$391.90 M(-58.3%) | -$1.37 B(-51.4%) |
| Dec 1999 | -$2.82 B(>+9900.0%) | -$940.20 M(-14.4%) | -$2.82 B(+48.8%) |
| Sept 1999 | - | -$1.10 B(-203.4%) | -$1.89 B(-528.2%) |
| June 1999 | - | $1.06 B(-157.7%) | $442.20 M(-134.5%) |
| Mar 1999 | - | -$1.84 B(>+9900.0%) | -$1.28 B(>+9900.0%) |
| Dec 1998 | -$11.40 M(-99.3%) | -$16.90 M(-101.4%) | -$11.40 M(-97.7%) |
| Sept 1998 | - | $1.24 B(-286.6%) | -$504.50 M(-65.9%) |
| June 1998 | - | -$663.30 M(+16.6%) | -$1.48 B(-19.1%) |
| Mar 1998 | - | -$569.00 M(+11.6%) | -$1.83 B(+14.1%) |
| Dec 1997 | -$1.60 B(-19.0%) | -$510.00 M(-294.5%) | -$1.60 B(-17.1%) |
| Sept 1997 | - | $262.20 M(-125.9%) | -$1.93 B(-39.7%) |
| June 1997 | - | -$1.01 B(+195.8%) | -$3.20 B(+84.6%) |
| Mar 1997 | - | -$342.30 M(-59.3%) | -$1.74 B(-12.3%) |
| Dec 1996 | -$1.98 B(+49.7%) | -$840.50 M(-16.7%) | -$1.98 B(-24.7%) |
| Sept 1996 | - | -$1.01 B(-321.4%) | -$2.63 B(+31.1%) |
| June 1996 | - | $455.60 M(-177.8%) | -$2.01 B(-31.5%) |
| Mar 1996 | - | -$585.50 M(-60.7%) | -$2.93 B(+121.3%) |
| Dec 1995 | -$1.32 B(+3981.2%) | -$1.49 B(+286.5%) | -$1.32 B(-215.6%) |
| Sept 1995 | - | -$385.60 M(-17.1%) | $1.14 B(+11.7%) |
| June 1995 | - | -$465.00 M(-145.7%) | $1.02 B(+6.6%) |
| Mar 1995 | - | $1.02 B(+4.4%) | $960.70 M(-3065.1%) |
| Dec 1994 | -$32.40 M(-98.7%) | $975.80 M(-293.2%) | -$32.40 M(-99.1%) |
| Sept 1994 | - | -$505.10 M(-4.4%) | -$3.41 B(+38.6%) |
| June 1994 | - | -$528.50 M(-2180.7%) | -$2.46 B(+7.5%) |
| Mar 1994 | - | $25.40 M(-101.1%) | -$2.29 B(-11.4%) |
| Dec 1993 | -$2.59 B(+91.4%) | -$2.41 B(-640.4%) | -$2.59 B(+363.2%) |
| Sept 1993 | - | $445.30 M(-224.6%) | -$558.70 M(-61.9%) |
| June 1993 | - | -$357.50 M(+32.9%) | -$1.46 B(+7.7%) |
| Mar 1993 | - | -$269.00 M(-28.7%) | -$1.36 B(+0.6%) |
| Dec 1992 | -$1.35 B(+3.9%) | -$377.50 M(-18.0%) | -$1.35 B(+1.6%) |
| Sept 1992 | - | -$460.50 M(+81.9%) | -$1.33 B(+7.0%) |
| June 1992 | - | -$253.10 M(-3.0%) | -$1.24 B(+2.7%) |
| Mar 1992 | - | -$260.80 M(-26.7%) | -$1.21 B(-7.0%) |
| Dec 1991 | -$1.30 B(+30.1%) | -$355.90 M(-4.6%) | -$1.30 B(+13.4%) |
| Sept 1991 | - | -$373.10 M(+69.7%) | -$1.15 B(+19.7%) |
| June 1991 | - | -$219.90 M(-37.5%) | -$958.50 M(-4.0%) |
| Mar 1991 | - | -$351.70 M(+73.6%) | -$998.10 M(-0.2%) |
| Dec 1990 | -$999.80 M(+79.2%) | -$202.60 M(+9.9%) | -$999.80 M(+25.4%) |
| Sept 1990 | - | -$184.30 M(-29.0%) | -$797.20 M(+30.1%) |
| June 1990 | - | -$259.50 M(-26.6%) | -$612.90 M(+73.4%) |
| Mar 1990 | - | -$353.40 M | -$353.40 M |
| Dec 1989 | -$558.00 M | - | - |
FAQ
- What is Merck & Co annual cash flow from investing activities?
- What is the all time high annual CFI for Merck & Co?
- What is Merck & Co annual CFI year-on-year change?
- What is Merck & Co quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Merck & Co?
- What is Merck & Co quarterly CFI year-on-year change?
- What is Merck & Co TTM cash flow from investing activities?
- What is the all time high TTM CFI for Merck & Co?
- What is Merck & Co TTM CFI year-on-year change?
What is Merck & Co annual cash flow from investing activities?
The current annual CFI of MRK is -$14.08 B
What is the all time high annual CFI for Merck & Co?
Merck & Co all-time high annual cash flow from investing activities is $4.31 B
What is Merck & Co annual CFI year-on-year change?
Over the past year, MRK annual cash flow from investing activities has changed by -$9.12 B (-183.93%)
What is Merck & Co quarterly cash flow from investing activities?
The current quarterly CFI of MRK is -$3.85 B
What is the all time high quarterly CFI for Merck & Co?
Merck & Co all-time high quarterly cash flow from investing activities is $12.01 B
What is Merck & Co quarterly CFI year-on-year change?
Over the past year, MRK quarterly cash flow from investing activities has changed by -$3.51 B (-1051.20%)
What is Merck & Co TTM cash flow from investing activities?
The current TTM CFI of MRK is -$6.24 B
What is the all time high TTM CFI for Merck & Co?
Merck & Co all-time high TTM cash flow from investing activities is $15.57 B
What is Merck & Co TTM CFI year-on-year change?
Over the past year, MRK TTM cash flow from investing activities has changed by +$9.65 B (+60.73%)